Sentiment for Fluidigm Corp (NASDAQ:FLDM)
Fluidigm Corp (NASDAQ:FLDM) institutional sentiment decreased to 1.7 in Q2 2019. Its down -1.68, from 3.38 in 2019Q1. The ratio dropped, as 78 investment professionals increased and started new holdings, while 46 sold and reduced their stakes in Fluidigm Corp. The investment professionals in our partner’s database now hold: 53.97 million shares, down from 94.53 million shares in 2019Q1. Also, the number of investment professionals holding Fluidigm Corp in their top 10 holdings decreased from 3 to 1 for a decrease of 2. Sold All: 16 Reduced: 30 Increased: 45 New Position: 33.
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. The company has market cap of $179.48 million. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. It currently has negative earnings. The firm also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules.
The stock increased 7.95% or $0.19 during the last trading session, reaching $2.58. About 739,105 shares traded. Fluidigm Corporation (NASDAQ:FLDM) has risen 94.54% since December 4, 2018 and is uptrending. It has outperformed by 94.54% the S&P500.
Analysts await Fluidigm Corporation (NASDAQ:FLDM) to report earnings on February, 6. They expect $-0.13 EPS, up 27.78 % or $0.05 from last year’s $-0.18 per share. After $-0.14 actual EPS reported by Fluidigm Corporation for the previous quarter, Wall Street now forecasts -7.14 % EPS growth.
Perkins Capital Management Inc holds 2.57% of its portfolio in Fluidigm Corporation for 297,800 shares. Pura Vida Investments Llc owns 240,000 shares or 0.86% of their US portfolio. Moreover, Driehaus Capital Management Llc has 0.83% invested in the company for 2.14 million shares. The California-based Eam Investors Llc has invested 0.67% in the stock. Granahan Investment Management Inc Ma, a Massachusetts-based fund reported 735,388 shares.
Since January 1, 0001, it had 4 insider purchases, and 8 sales for $16.94 million activity.
More notable recent Fluidigm Corporation (NASDAQ:FLDM) news were published by: Nasdaq.com which released: “Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6% – Nasdaq” on November 06, 2019, also Globenewswire.com with their article: “Jonathan Day Named VP, Commercial Operations, Americas – GlobeNewswire” published on August 01, 2019, Globenewswire.com published: “Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer – GlobeNewswire” on June 04, 2019. More interesting news about Fluidigm Corporation (NASDAQ:FLDM) were released by: Nasdaq.com and their article: “French glass bottle maker Verallia raises 2019 guidance – Nasdaq” published on November 07, 2019 as well as Streetinsider.com‘s news article titled: “After-Hours Movers 11/05: (FIVM) (LUNA) (DVA) Higher; (PLT) (FLDM) (MTCH) Lower (more…) – StreetInsider.com” with publication date: November 05, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.